Atlas Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-150
Closed -$8.37K 973
2021
Q4
$8.37K Hold
150
﹤0.01% 744
2021
Q3
$8.71K Sell
150
-199
-57% -$12.3K ﹤0.01% 744
2021
Q2
$22.1K Buy
+349
New +$23K ﹤0.01% 640
2020
Q2
Sell
-240
Closed -$9.32K 745
2020
Q1
$9.32K Hold
240
﹤0.01% 586
2019
Q4
$13.6K Buy
+240
New +$13.4K ﹤0.01% 566

Other funds holding XRAY

Atlas Capital Advisors's XRAY Position: Q1 2022 in Review

Atlas Capital Advisors sold out of Dentsply Sirona (XRAY) in Q1 2022, closing a stake of 150 shares — an estimated $8.37K sold.

Atlas Capital Advisors first reported a position in XRAY in Q4 2019 and held it in 5 quarters. The position peaked at $22.1K in Q2 2021. 536 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.

  • Atlas Capital Advisors reported no remaining Dentsply Sirona position as of Q1 2022 after selling out during the quarter.
  • Atlas Capital Advisors sold 150 Dentsply Sirona shares in Q1 2022, an estimated $8.37K.
  • Atlas Capital Advisors first reported a position in Dentsply Sirona in Q4 2019 and held it in 5 quarters.
  • Atlas Capital Advisors's Dentsply Sirona position peaked at $22.1K in Q2 2021.
  • 536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.

Based on Atlas Capital Advisors's 13F filing for Q1 2022, filed 11 May 2022.